Because of their essential role as members of the “tri-molecular complex”, formed by HLA-DRB1, MPB and T-cell receptors α and β, the genes coding the T-cell receptor α and β chains are identified as primary candidate genes for the prediction of the susceptibility to MS and GA therapeutic responses. Here, HLA-DRB1 is linked to myeloid sarcoma.